Development of Biodegradable Polymeric Stents for the Treatment of Cardiovascular Diseases
Cardiovascular disease has become the leading cause of death. A vascular stent is an effective means for the treatment of cardiovascular diseases. In recent years, biodegradable polymeric vascular stents have been widely investigated by researchers because of its degradability and clinical application potential for cardiovascular disease treatment. Compared to non-biodegradable stents, these stents are designed to degrade after vascular healing, leaving regenerated healthy arteries. This article reviews and summarizes the recent advanced methods for fabricating biodegradable polymeric stents, including injection molding, weaving, 3D printing, and laser cutting. Besides, the functional modification of biodegradable polymeric stents is also introduced, including visualization, anti-thrombus, endothelialization, and anti-inflammation. In the end, the challenges and future perspectives of biodegradable polymeric stents were discussed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Biomolecules - 12(2022), 9 vom: 06. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shen, Yihong [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biodegradable polymeric stents |
|---|
| Anmerkungen: |
Date Completed 26.09.2022 Date Revised 18.10.2022 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.3390/biom12091245 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34655456X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34655456X | ||
| 003 | DE-627 | ||
| 005 | 20231226031734.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/biom12091245 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1155.xml |
| 035 | |a (DE-627)NLM34655456X | ||
| 035 | |a (NLM)36139086 | ||
| 035 | |a (PII)1245 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shen, Yihong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development of Biodegradable Polymeric Stents for the Treatment of Cardiovascular Diseases |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.09.2022 | ||
| 500 | |a Date Revised 18.10.2022 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Cardiovascular disease has become the leading cause of death. A vascular stent is an effective means for the treatment of cardiovascular diseases. In recent years, biodegradable polymeric vascular stents have been widely investigated by researchers because of its degradability and clinical application potential for cardiovascular disease treatment. Compared to non-biodegradable stents, these stents are designed to degrade after vascular healing, leaving regenerated healthy arteries. This article reviews and summarizes the recent advanced methods for fabricating biodegradable polymeric stents, including injection molding, weaving, 3D printing, and laser cutting. Besides, the functional modification of biodegradable polymeric stents is also introduced, including visualization, anti-thrombus, endothelialization, and anti-inflammation. In the end, the challenges and future perspectives of biodegradable polymeric stents were discussed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a biodegradable polymeric stents | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a functionalization | |
| 650 | 4 | |a manufacturing method | |
| 650 | 7 | |a Polymers |2 NLM | |
| 700 | 1 | |a Yu, Xiao |e verfasserin |4 aut | |
| 700 | 1 | |a Cui, Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Yu, Fan |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Mingyue |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Yujie |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Jinglei |e verfasserin |4 aut | |
| 700 | 1 | |a Sun, Binbin |e verfasserin |4 aut | |
| 700 | 1 | |a Mo, Xiumei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Biomolecules |d 2011 |g 12(2022), 9 vom: 06. Sept. |w (DE-627)NLM228347106 |x 2218-273X |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2022 |g number:9 |g day:06 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/biom12091245 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2022 |e 9 |b 06 |c 09 | ||